|
Volumn 278, Issue 49, 2003, Pages 49378-49385
|
Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITRIOL;
CALCITRIOL RECEPTOR;
DRUG DERIVATIVE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ONCOPROTEIN;
PRIMER DNA;
RELB PROTEIN, HUMAN;
RELB PROTEIN, MOUSE;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR RELB;
ANIMAL;
ARTICLE;
CYTOLOGY;
DENDRITIC CELL;
DRUG EFFECT;
DRUG POTENTIATION;
FLUORESCENT ANTIBODY TECHNIQUE;
GENE EXPRESSION REGULATION;
GENETIC TRANSCRIPTION;
GENETICS;
HUMAN;
METABOLISM;
MOUSE;
MOUSE MUTANT;
NUCLEOTIDE SEQUENCE;
PHYSIOLOGY;
PROMOTER REGION;
ANIMALS;
BASE SEQUENCE;
CALCITRIOL;
DENDRITIC CELLS;
DNA PRIMERS;
FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT;
GENE EXPRESSION REGULATION;
HUMANS;
MICE;
MICE, KNOCKOUT;
NF-KAPPA B;
PROMOTER REGIONS (GENETICS);
PROTO-ONCOGENE PROTEINS;
RECEPTORS, CALCITRIOL;
TRANSCRIPTION FACTOR RELB;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
|
EID: 1542676905
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M308448200 Document Type: Article |
Times cited : (118)
|
References (0)
|